CIK 0001873835
- Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454869378
- Phone
- +1 888-958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 1 of 2 · 21 filings